Department of Medical Biology, Faculty of Medicine, Istanbul Aydin University, Istanbul, Turkey.
Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20192313.
The present study was aimed to investigate the relationship between NOD1/CARD4 and NOD2/CARD15 gene polymorphisms and osteoporosis in the Turkish population. The first time we thought that the functional polymorphisms in NOD1/CARD4 and NOD2/CARD15 genes might have triggered the development of osteoporosis. The objective of our study was to determine the relationship between NOD1/CARD4 and NOD2/CARD15 SNPs and osteoporosis. The NOD1/CARD4 (rs5743336) and NOD2/CARD15 (rs2066847) SNPs were analyzed by PCR restriction fragment length polymorphism (PCR-RFLP) in 94 healthy controls and 164 subjects with osteoporosis. PCR products were digested with restriction enzymes AvaI for NOD1/CARD4 and ApaI for NOD2/CARD15. We found that NOD1/CARD4 genotype distribution of AA, GA and GG were 15, 44 and 41% for patients and 17, 46 and 37% for controls, respectively. NOD2/CARD15 mutation was found only in three patients (1.8%) as heterozygote. The results did not show any statistical difference between NOD1/CARD4 and NOD2/CARD15 genotype distribution of patients and healthy groups (χ2 = 1.740, P=0.187; χ2 = 1.311, P=0.519). However, the most frequent AG genotype (46%) of NOD1/CARD4 was observed in healthy controls, GG genotype (44%) of NOD1/CARD4 was observed as the most frequent in osteoporotic patients. NOD2/CARD15 WT/WT genotype, the most frequent genotype, was observed in both groups. Statistical analysis revealed that NOD1/CARD4 and NOD2/CARD15 polymorphisms are not associated with osteoporosis. However, a definite judgement is difficult to be made due to restricted number of patients and small size of control group. Further research is sorely warranted in this direction.
本研究旨在探讨 NOD1/CARD4 和 NOD2/CARD15 基因多态性与土耳其人群骨质疏松症之间的关系。我们首次认为 NOD1/CARD4 和 NOD2/CARD15 基因的功能多态性可能引发了骨质疏松症的发展。本研究的目的是确定 NOD1/CARD4 和 NOD2/CARD15 SNPs 与骨质疏松症之间的关系。通过聚合酶链反应限制性片段长度多态性(PCR-RFLP)分析 94 名健康对照者和 164 名骨质疏松症患者的 NOD1/CARD4(rs5743336)和 NOD2/CARD15(rs2066847)SNP。PCR 产物用限制性内切酶 AvaI 消化 NOD1/CARD4 和 ApaI 消化 NOD2/CARD15。我们发现,NOD1/CARD4 基因型分布为 AA、GA 和 GG 分别为患者的 15%、44%和 41%,对照组的 17%、46%和 37%。NOD2/CARD15 突变仅在 3 名患者(1.8%)中发现为杂合子。患者与健康组 NOD1/CARD4 和 NOD2/CARD15 基因型分布之间无统计学差异(χ2 = 1.740,P=0.187;χ2 = 1.311,P=0.519)。然而,NOD1/CARD4 最常见的 AG 基因型(46%)见于健康对照组,NOD1/CARD4 最常见的 GG 基因型(44%)见于骨质疏松症患者。NOD2/CARD15 WT/WT 基因型,即最常见的基因型,在两组中均观察到。统计分析表明,NOD1/CARD4 和 NOD2/CARD15 多态性与骨质疏松症无关。然而,由于患者数量有限且对照组规模较小,因此难以做出明确判断。在这方面需要进一步的研究。